Uric acid and hypertension: a focused review and practical recommendations.

Détails

ID Serval
serval:BIB_D86C325760F0
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Uric acid and hypertension: a focused review and practical recommendations.
Périodique
Journal of hypertension
Auteur⸱e⸱s
De Becker B., Borghi C., Burnier M., van de Borne P.
ISSN
1473-5598 (Electronic)
ISSN-L
0263-6352
Statut éditorial
Publié
Date de publication
05/2019
Peer-reviewed
Oui
Volume
37
Numéro
5
Pages
878-883
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review
Publication Status: ppublish
Résumé
: Uric acid levels are higher in humans than in other mammals. Best known as an extracellular antioxidant, uric acid also increases salt sensitivity, fat storage, and lipogenesis. Xanthine oxidase-related oxidative stress may also induce endothelial dysfunction and renal vasoconstriction. Renal structure abnormalities contribute to salt-sensitive and uric acid-independent hypertension. Maternal hyperuricemia during pregnancy and hyperuricemia early in life are likewise independent risk factors for hypertension. Genetic polymorphism is potentially involved in the activity of xanthine oxidoreductase, but further studies are needed. Xanthine oxidase inhibition consistently decreases blood pressure in younger hypertensive patients, albeit modestly. Hyperuricemia affects one out of five adults as a result of the Western diet, insulin resistance, and renal dysfunction. This review advocates lifestyle changes to maintain uric acid levels within the normal range in young (pre)hypertensive individuals or normotensives with a family history of hypertension, metabolic disorders, or obesity; moreover, antihypertensive medications that increase uric acid levels should be avoided.
Mots-clé
Animals, Antioxidants/therapeutic use, Blood Pressure, Enzyme Inhibitors/therapeutic use, Humans, Hypertension/blood, Hypertension/complications, Hyperuricemia/complications, Kidney/abnormalities, Kidney Diseases, Oxidative Stress, Risk Factors, Uric Acid/blood, Urogenital Abnormalities/complications, Xanthine Oxidase/antagonists & inhibitors
Pubmed
Web of science
Création de la notice
03/02/2019 16:10
Dernière modification de la notice
16/02/2021 7:27
Données d'usage